Pharmacotherapy for opioid addiction in community corrections

References

• Anglin, M. D. (1988). The efficacy of civil commitment in treating narcotic addiction. NIDA Research Monograph, 86, 8–34.
   PubMedGoogle Scholar
• Anglin, M. D., Brecht, M., & Maddahian, E. (1989). Pretreatment characteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology, 27, 537–557. doi:10.1111/j.1745-9125.1989.tb01045.x
   Web of Science ®Google Scholar
• Anglin, M. D., Longshore, D., & Turner, T. (1999). Treatment Alternatives to Street Crime. An Evaluation of Five Programs. Criminal Justice and Behavior, 26, 168–195. doi:10.1177/0093854899026002002
   Web of Science ®Google Scholar
• Anglin, M. D., McGlothlin, W. H., & Speckart, G. (1981). The effect of parole on methadone patient behavior. American Journal of Drug and Alcohol Abuse, 8, 153–170. doi:10.3109/00952998108999122
   PubMed Web of Science ®Google Scholar
• Ball, J. C., & Ross, A. (1991). Effectiveness of methadone maintenance treatment: Patients, programs, services, and outcome. New York: Springer-Verlag.
   Google Scholar
• Ball, J. C., Shaffer, J. W., & Nurco, D. N. (1983). The day-to-day criminality of heroin addicts in Baltimore–a study in the continuity of offence rates. Drug and Alcohol Dependence, 12, 119–142. doi:10.1016/0376-8716(83)90037-6
   PubMed Web of Science ®Google Scholar
• Bonnie, R. (2006). Judicially mandated naltrexone use by criminal offenders: A legal analysis. Journal of Substance Abuse Treatment, 31, 121–127. doi:10.1016/j.jsat.2006.06.003
   PubMed Web of Science ®Google Scholar
• Brecht, M. L., Anglin, M. D., & Wang, J. C. (1993). Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients. American Journal of Drug and Alcohol Abuse, 19, 89–106. doi:10.3109/00952999309002668
   PubMed Web of Science ®Google Scholar
• Brill, L., & Lieberman, L. (1969). Authority and addiction. Boston, MA: Little, Brown & Company.
   Google Scholar
• Bureau of Justice Statistics. (2018a). Probation. Retrieved from https://www.bjs.gov/index.cfm?ty=tp&tid=151
   Google Scholar
• Bureau of Justice Statistics. (2018b). Parole. Retrieved from https://www.bjs.gov/index.cfm?ty=tp&tid=152
   Google Scholar
• Center for Disease Control and Prevention (CDC) (2018). Retrieved from https://www.cdc.gov/drugoverdose/index.html
   Google Scholar
• Chaiken, J., & Chaiken, M. (1990). Drugs and predatory crime. In M. Tonry & J. Q. Wilson (Eds.), Drugs and crime. Chicago, IL: University of Chicago Press.
   Google Scholar
• Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009). Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA, 301, 183–190. doi:10.1001/jama.2008.976
   PubMed Web of Science ®Google Scholar
• Clark, C. B., Hendricks, P. S., Lane, P. S., Trent, L., & Cropsey, K. L. (2014). Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision. Addictive Behaviors, 39, 1736–1740. doi:10.1016/j.addbeh.2014.07.011
   PubMed Web of Science ®Google Scholar
• Cornish, J. W., Metzger, D., Woody, G. E., Wilson, D., McLellan, A. T., Vandergrift, B., & O'Brien, C. P. (1997). Naltrexone pharmacotherapy for opioid dependent federal probationers. Journal of Substance Abuse Treatment, 14, 529–534. doi:10.1016/S0740-5472(97)00020-2
   PubMed Web of Science ®Google Scholar
• Coviello, D. M., Cornish, J. W., Lynch, K. G., Alterman, A. I., & O'Brien, C. P. (2010). A randomized trial of oral naltrexone for treating opioid-dependent offenders. American Journal on Addictions, 19, 422–432. doi:10.1111/j.1521-0391.2010.00070.x
   PubMed Web of Science ®Google Scholar
• Coviello, D. M., Cornish, J. W., Lynch, K. G., Boney, T. Y., Clark, C. A., Lee, J. D., … O'Brien, C. P. (2012). A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Substance Abuse, 33, 48–59. doi:10.1080/08897077.2011.609438
   PubMed Web of Science ®Google Scholar
• Craddock, S. G., Rounds-Bryant, J. L., Flynn, P. M., & Hubbard, R. L. (1997). Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993. American Journal of Drug and Alcohol Abuse, 23, 43–59. doi:10.3109/00952999709001686
   PubMed Web of Science ®Google Scholar
• Crits-Christoph, P., Markell, H. M., Gibbons, M. B., Gallop, R., Lundy, C., Stringer, M., & Gastfriend, D. R. (2016). A naturalistic evaluation of extended-release naltrexone in clinical practice in Missouri. Journal of Substance Abuse Treatment, 70, 50–57. doi:10.1016/j.jsat.2016.07.014
   PubMed Web of Science ®Google Scholar
• Cropsey, K. L., Lane, P. S., Perkins, A. C., Clark, C. B., Hardy, S., McCullumsmith, C., & Stitzer, M. L. (2013). Buprenorphine and medication management in a community corrections population: A pilot study. Journal of Addiction Medicine, 7, 210–215. doi:10.1097/ADM.0b013e31828e6b21
   PubMed Web of Science ®Google Scholar
• Csete J., & Catania, H. (2013). Methadone treatment providers’ views of drug court policy and practice: a case study of New York State. Harm Reduction Journal, 10, 35. https://doi.org/10.1186/1477-7517-10-35
   PubMed Web of Science ®Google Scholar
• Cuellar, A., & Cheema, J. (2014). Health care reform, behavioral health and the criminal justice population. Journal of Behavioral Health Services & Research, 41, 447–459. doi:10.1007/s11414-014-9404-0
   PubMed Web of Science ®Google Scholar
• DeFleur, L. B., Ball, J. C., & Snarr, R. W. (1969). The long-term social correlates of opiate addiction. Social Problem, 17, 225–234. doi:10.2307/799868
   Web of Science ®Google Scholar
• Des Jarlais, D. C., Friedman, S. R., Sotheran, J. L., Wenston, J., Marmor, M., Yancovitz, S. R., … Mildvan, D. (1994). Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA, 271, 121–127. doi:10.1001/jama.271.2.121
   PubMed Web of Science ®Google Scholar
• Desmond, D., & Maddux, J. (1996). Compulsory supervision and methadone maintenance. Journal of Substance Abuse Treatment, 13, 79–83. doi:10.1016/0740-5472(95)02024-1
   PubMed Web of Science ®Google Scholar
• Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. D. (2005). Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction, 100, 820–828. doi:10.1111/j.1360-0443.2005.01050.x
   PubMed Web of Science ®Google Scholar
• Duvall, H. J., Locke, B. Z., & Brill, L. (1963). Followup study of narcotic drug addicts five years after hospitalization. Public Health Reports, 78, 185–194. doi:10.2307/4591754
   PubMed Web of Science ®Google Scholar
• Farabee, D., Prendergast, M., & Anglin, M. D. (1998). The effectiveness of coerced treatment for drug abusing offenders. Federal Probation, 62, 3–10.
   Google Scholar
• Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., … MAT Working Group Of, C. J. D. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Substance Abuse, 33, 9–18. doi:10.1080/08897077.2011.611460
   PubMed Web of Science ®Google Scholar
• Friedmann, P. D., Wilson, D., Knudsen, H. K., Ducharme, L. J., Welsh, W. N., Frisman, L., … Vocci, F. J. (2015). Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. Journal of Substance Abuse Treatment, 50, 50–58. doi:10.1016/j.jsat.2014.10.001
   PubMed Web of Science ®Google Scholar
• Glasscote, R., Sussex, J. N., Jaffe, J. H., Ball, J., & Brill, L. (1972). The treatment of drug abuse: Programs, problems, prospects. Washington, DC: American Psychiatric Association.
   Google Scholar
• Gordon, M. S., Kinlock, T. W., Schwartz, R. P., Couvillion, K. A., Sudec, L. J., O'Grady, K. E., … Shabazz, H. (2015). Buprenorphine treatment for probationers and parolees. Substance Abuse, 36, 217–225. doi:10.1080/08897077.2014.902787
   PubMed Web of Science ®Google Scholar
• Gryczynski, J., Kinlock, T. W., Kelly, S. M., O'Grady, K. E., Gordon, M. S., & Schwartz, R. P. (2012). Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime. Substance Abuse, 33, 30–39. doi:10.1080/08897077.2011.616816
   PubMed Web of Science ®Google Scholar
• Gryczynski, J., Schwartz, R. P., Salkever, D. S., Mitchell, S. G., & Jaffe, J. H. (2011). Patterns in admission delays to outpatient methadone treatment in the United States. Journal of Substance Abuse Treatment, 41, 431–439. doi:10.1016/j.jsat.2011.06.005
   PubMed Web of Science ®Google Scholar
• Hedrich, D., Alves, P., Farrell, M., Stover, H., Moller, L., & Mayet, S. (2012). The effectiveness of opioid maintenance treatment in prison settings: A systematic review. Addiction, 107, 501–517. doi:10.1111/j.1360-0443.2011.03676.x
   PubMed Web of Science ®Google Scholar
• Hiller, M. L., Simpson, D. D., Broome, K. M., & Joe, G. W. (2000). Legal status at Intake and post-treatment incarceration: 12 month follow-up of methadone maintenance treatment. Journal of Maintenance in the Addictions, 1, 27–43. doi:10.1300/J126v01n04_04
   Google Scholar
• Hubbard, R. L., Collins, J. J., Rachal, J. V., & Cavanaugh, E. R. (1988). The criminal justice client in drug abuse treatment. NIDA Research Monograph, 86, 57–80.
   PubMedGoogle Scholar
• Hubbard, R. L., Craddock, G., Flynn, P. M., Anderson, J., & Etheridge, R. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11, 261–278. doi:10.1037/0893-164X.11.4.261
   Web of Science ®Google Scholar
• Inciardi, J. A. (1988a). Some considerations on the clinical efficacy of compulsory treatment: reviewing the New York experience in compulsory treatment of drug abuse: Research and clinical practice. In C. G. Leukefeld & F. M. Tims (Eds.), NIDA Research Monograph (p. 86). Rockville, MD: US Dept HHS.
   Google Scholar
• Inciardi, J. A. (1988b). Compulsory treatment in New York: A brief narrative history of misjudgment, mismanagement, and misrepresentation. Journal of Drug Issues, 4, 547–560. doi:10.1177/002204268801800404
   Web of Science ®Google Scholar
• Inciardi, J. A. (1990). Handbook of drug control in the United States. Westport, CT: Greenwood Press.
   Google Scholar
• Inciardi, J. A. (2008). The war on drugs IV: The continuing saga of the mysteries and miseries of intoxication, addition, crime, and public policy. Boston, MA: Allyn and Bacon.
   Google Scholar
• Jain, A., Christopher, P., & Appelbaum, P. S. (2018). Civil commitment for opioid and other substance use disorders: Does it work? Psychiatric Services, 69, 374–376. doi:10.1176/appi.ps.201800066
   PubMed Web of Science ®Google Scholar
• Joseph, H. (1973). Probation department treats heroin addicts. Federal Probation, 37, 35–39.
   Google Scholar
• Joseph, H. (1988). The criminal justice system and opiate addiction: a historical perspective. NIDA Research Monograph, 86, 106–125.
   PubMedGoogle Scholar
• Joseph, H., & Callanan, T. J. (1974). Methadone maintenance programs for probationers in New York City. International Journal of Offender Therapy and Comparative Criminology, 18, 104–106. doi:10.1177/0306624X7401800116
   Web of Science ®Google Scholar
• Joseph, H., & Dole, V. P. (1970). Methadone patients on probation and parole. Federal Probation, 34, 42–48.
   Google Scholar
• Kelly, S. M., O'Grady, K. E., Jaffe, J. H., Gandhi, D., & Schwartz, R. P. (2013). Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment. Journal of Addiction Medicine, 7, 133–138. doi:10.1097/ADM.0b013e318284a0c1
   PubMed Web of Science ®Google Scholar
• Kramer, J. C., Bass, R. A., & Berecochea, J. E. (1968). Civil commitment for addicts: The California program. American Journal of Psychiatry, 125, 816–824. doi:10.1176/ajp.125.6.816
   PubMed Web of Science ®Google Scholar
• Krupitsky, E., Nunes, E. V., Ling, W., Illeperuma, A., Gastfriend, D. R., & Silverman, B. L. (2011). Injectable extended-release naltrexone for opioid dependence. Lancet, 377, 1506–1513. doi:10.1016/S0140-6736(11)60358-9
   PubMed Web of Science ®Google Scholar
• Langenauer, B. J., & Bowden, C. L. (1971). A follow-up study of narcotic addicts in the NARA program. American Journal of Psychiatry, 128, 41–46. doi:10.1176/ajp.128.1.41
   PubMed Web of Science ®Google Scholar
• Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A. Jr., … O'Brien, C. P. (2016). Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. New England Journal of Medicine, 374, 1232–1242. doi:10.1056/NEJMoa1505409
   PubMed Web of Science ®Google Scholar
• Lee, J. D., Nunes, E. V. Jr., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., … Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. Lancet, 391, 309–318. doi:10.1016/S0140-6736(17)32812-X
   PubMed Web of Science ®Google Scholar
• Markman, J., Durose, M., Rantala, R., & Tiedt, A. (2016). Recidivism of offenders placed on federal community supervision in 2005: Patterns from 2005 to 2010. Bureau of Justice Statistics. June 2016; NCJ 249743.
   Google Scholar
• Marlowe, D. B., Hardin, C. D., & Fox, C. L. (2016). Painting the current picture: A national report on drug courts and other problem solving courts in the United States. Alexandria, VA: National Drug Court Institute. Retrieved from http://www.ndcrc.org/sites/default/les/pcp_ nal_version.pdf
   Google Scholar
• Mathers, B. M., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R. P., … 2009 Reference Group to the UN on HIV and Injecting Drug Use. (2010). HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet, 375, 1014–1028. doi:10.1016/S0140-6736(10)60232-2
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, (3), CD002209. doi:10.1002/14651858.CD002209.pub2
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, (2), CD002207. doi:10.1002/14651858.CD002207.pub4
   PubMed Web of Science ®Google Scholar
• Matusow, H., Dickman, S. L., Rich, J. D., Fong, C., Dumont, D. M., Hardin, C., … Rosenblum, A. (2013). Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment, 44, 473–480. doi:10.1016/j.jsat.2012.10.004
   PubMed Web of Science ®Google Scholar
• Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., … Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. [Research Support, U.S. Gov't, P.H.S.]. Journal of Acquired Immune Deficiency Syndromes, 6, 1049–1056.
   PubMed Web of Science ®Google Scholar
• Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. (2011). Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Systematic Reviews, (2), CD001333. doi:10.1002/14651858.CD001333.pub3
   Google Scholar
• Mitchell, S. G., Gryczynski, J., Kelly, S. M., O'Grady, K. E., Jaffe, J. H., Olsen, Y. K., & Schwartz, R. (2014). Treatment outcomes of African American buprenorphine patients by parole and probation status. Journal of Drug Issues, 44, 69–82. doi:10.1177/0022042613491106
   PubMed Web of Science ®Google Scholar
• Mitchell, S. G, Willet, J., Monico, L., James, A., Rudes, D., Viglioni, J., … Friedmann, P. (2016). Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices Substance Abuse, 37, 127–133. doi:10.1080/08897077.2015.1129389
   PubMed Web of Science ®Google Scholar
• Musto, D. (1987). The American disease. Origins of narcotic control. New York: Oxford University Press.
   Google Scholar
• Musto, D. F., & Ramos, M. R. (1981). Notes on American medical history: A follow-up study of the New Haven morphine maintenance clinic of 1920. New England Journal of Medicine, 304, 1071–1077. doi:10.1056/NEJM198104303041804
   PubMed Web of Science ®Google Scholar
• National Association of Drug Court Professionals (NADCP). (2011). Resolution of the Board of Directors on the availability of medically assisted treatment (M.A.T.) for addiction in Drug Courts. Alexandria, VA: Author. Retrieved from http://www.nadcp.org/sites/default/les/nadcp/NADCP Board Statement on MAT.pdf
   Google Scholar
• National Institute of Justice. (2018). Office of Justice Programs. Drug courts. Available at https://www.nij.gov/topics/courts/drug-courts/Pages/welcome.aspx
   Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet, 378, 571–583. doi:10.1016/S0140-6736(11)61097-0
   PubMed Web of Science ®Google Scholar
• Nurco, D. N., Hanlon, T. E., Kinlock, T. W., & Duszynski, K. R. (1988). Differential criminal patterns of narcotic addicts over an addiction career. Criminology, 26, 407–423. doi:10.1111/j.1745-9125.1988.tb00848.x
   Web of Science ®Google Scholar
• Perry, A. E., Neilson, M., Martyn-St James, M., Glanville, J. M., Woodhouse, R., Godfrey, C., & Hewitt, C. (2015). Pharmacological interventions for drug-using offenders. Cochrane Database of Systematic Reviews, (6), CD010862. doi:10.1002/14651858.CD010862.pub2
   PubMedGoogle Scholar
• Robertson, A. G., & Swartz, M. S. (2018). Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment. Journal of Substance Abuse Treatment, 85, 101–104. doi:10.1016/j.jsat.2017.02.016
   PubMed Web of Science ®Google Scholar
• Schwartz, R. P., Jaffe, J. H., O'Grady, K. E., Kinlock, T. W., Gordon, M. S., Kelly, S. M., … Ahmed, A. (2009). Interim methadone treatment: Impact on arrests. Drug and Alcohol Dependence, 103, 148–154. doi:10.1016/j.drugalcdep.2009.03.007
   PubMed Web of Science ®Google Scholar
• Sharma, A., O'Grady, K. E., Kelly, S. M., Gryczynski, J., Mitchell, S. G., & Schwartz, R. P. (2016). Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Substance Abuse and Rehabilitation, 7, 27–40. doi:10.2147/SAR.S81602
   PubMed Web of Science ®Google Scholar
• Simpson, D. D., Savage, J., Lloyd, M. R., & Sells, S. B. (1978). Evaluation of drug abuse treatments based on first year follow up.
   Google Scholar
• Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., … Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ, 357, p j1550. doi:10.1136/bmj.j1550
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/. Retrieved July 3, 2018.
   Google Scholar
• Tieman, C. (1981). From victims to criminals to victims: A review of the issues. In J. A. Inciardi (Ed.), The drugs-crime connection. Beverly Hills: Sage Publications 1981.
   Google Scholar
• Tonry, M. (2011). The oxford handbook of crime and criminal justice New York, NY: Oxford University Press.
   Google Scholar
• U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Assistance. (2015). Adult drug court discretionary grant program FY 2015 competitive grant announcement (OMB No. 1121-0329). Retrieved from https://www.bja.gov/Funding/15DrugCourtSol.pdf
   Google Scholar
• Welsh, W., Knudsen, H., Knight, K., Ducharme, L., Pankow, J, Urbine, T., … Friedman, P. (2015). Effects of an organizational linkage intervention on inter-organizational service coordination between parole/probation agencies and community treatment providers Administration and Policy in Mental Health and Mental Health Services Research, 43, 105–121. doi:10.1007/s10488-014-0623-8
   Web of Science ®Google Scholar